One thing boomers learn fast: Medicare and other insurance plans don’t
pay for hearing aids. And those buggers can cost up to $4,000 – $5,000 a
pair. There’s perhaps no one who knows these facts better than the man
who invented the Lyric hearing aid, which, on a subscription basis,
cost that much per pair per year! Now, that man, Adnan Shannib,
has invented iHear, the hearing aid for the 99 percent of us who would
love to hear, but can’t afford those Lyric prices. It’s the iHear, and
wait ’til you see what’s different about these hearing aids!
Wearable technology is a burgeoning fiscal force in South Korea and the Korean government is pushing for K-Glass innovations. What is K-Glass? What advantages to Google Glass does it offer to lovers of wearable technology in general and head mounted displays specifically? Read on for some interesting answers.
Suffering from hayfever? A new treatment that doesn’t involve taking
antihistamines every day for the rest of your life is in the works. It’s
called Allergia, and it’s a phototherapeutic medical device that
suppresses the sneezing, runny nose and nasal congestion of seasonal allergenic rhinitis (SAR).
Perhaps you’ve read that the American College of Cardiology (ACC) and
the American Heart Association (AHA) issued new guidelines on which
persons should take statin drugs for the prevention of heart disease
and stroke. On March 19, 2014, in the New England Journal of Medicine,
the AHA presented these guidelines, including age, gender, and race, as
well as various pre-existing health conditions that might call for
statin intervention. But what do the new guidelines mean for you?
Who wouldn’t love to see in the dark? An idea best remembered
from the rainy Tyrannosaurus Rex scene in the original Jurassic Park
movie in 1987, night vision, without clunky technology, is finally getting closer to reality. Researchers at University of Michigan have developed a prototype using graphene to embed into a contact lens or smart
phone camera lens.
Avoid Prescription Drugs: Electrocute Yourself With Electrocueticals Instead
Posted in: Today's ChiliWith all the controversy of Zohydro
(a painkiller that is about to receive FDA approval despite an 11-2
vote against it by independent experts), the field of electroceuticals
has been launched back into the news: the field of bioelectronics to develop alternatives to
drugs to manipulate the nervous system.
Today the FDA gave approval to the Nucleus Hybrid L24 Cochlear Implant System, the first implantable hearing device for adults
with the most common type of hearing loss: profound sensorineural hearing loss, that happens as a result of aging, hereditary, or just from attending too many heavy metal concerts.